MOPA -- Media, All-In-One Agency, Blockchain Development
Social Media/Email
  • WORK
  • NEWS
  • SERVICE
  • CONTACT

GenScript ProBio and DAAN Bio Therapeutics Cooperate for innovation drug discovery & development

7/14/2022

0 Comments

 
Picture
Brian Hosung Min, CEO, GenScript ProBio (Left); Byoung Chul Cho, Co-Founder & CEO, DAAN Bio Therapeutics (Right)
Source: GenScript ProBio, DAAN Bio Therapeutics

Jul.14.2022, Shanghai ------ GenScript ProBio, a global pharmaceutical contract development and manufacturing organization (CDMO), and DAAN Bio Therapeutics, an innovative new drug developer such as antibody treatments and cell therapy drugs, announced that they had entered into a strategic cooperation ​Memorandum of Understanding (MOU), regarding the development for innovation drug discovery & development. GenScript ProBio and DAAN have agreed to strengthen their cooperation in the cell and gene therapy (CGT) and biologics field through this MOU.

Through this agreement, both companies will strategically cooperate in the overall development process, such as discovery, manufacturing, and clinical trials of antibody and cell treatments, and related research and service projects.
​
DAAN Bio Therapeutics has conducted single cell transcriptomic and proteomic biomarker analysis through its own analysis platform using tissues secured from solid cancer patients along with DAAN Cancer Research Institute and Yonsei New Il Han Institute for Integrative Cancer Research.

Accordingly, DAAN Bio Therapeutics signed a contract manufacturing organization (CMO) service through GenScript ProBio to develop antibodies that specifically bind to the discovered target material, and established its own bispecific antibody production pipeline using antibodies derived through GMP production.
Picture
Brian Hosung Min, CEO, GenScript ProBio
​Brian H. Min, CEO of GenScript ProBio, said "I hope this strategic partnership with DAAN Bio Therapeutics will be of great support as a global partner in accelerating the development of DAAN's antibody and cell therapy through the GenScript ProBio's one-stop CDMO service platform. "

Picture
Byoung Chul Cho, Co-Founder & CEO, DAAN Bio Therapeutics
Byoung Chul Cho, Co-Founder & CEO of DAAN Bio Therapeutics, said "This strategic cooperation will be an opportunity to revitalize the development of antibody and cell therapy that control unique cancer treatment targets secured by DAAN Bio Therapeutics using GenScript ProBio's qualified and competitive technologies."

​Through this strategic partnership, both GenScript ProBio and DAAN Bio Therapeutics will continue their cooperation more closely with each other to develop subsequent pipelines of DAAN Bio Therapeutics, such as antibody drug and cell therapy.
Picture
DAAN
About DAAN Bio Therapeutics

Developer of integrated immune-oncology drug research platform intended to find various treatment strategies and develop novel drugs for lung cancer therapy. The company focuses on immune cell based anticancer therapy using NK cells and T cell receptors, and clinical trials based on independent research infrastructure, enabling patients to receive new drugs for cancer and get cured. 

www.daancancer.com 
Picture
GenScript ProBio
About GenScript ProBio

GenScript ProBio is the subsidiary of GenScript Biotech Corporation, proactively providing end-to-end CDMO service from drug discovery to commercialization with proactive strategies, professional solutions and efficient processes in cell and gene therapy (CGT), vaccine, biologics discovery and antibody protein drug to accelerate drug development for customers. GenScript ProBio has established companies in the United States, the Netherlands, South Korea, Shanghai, Hong Kong, Nanjing and other places to serve global customers, and supported customers in the United States, Europe, Asia Pacific and other regions to obtain more than 30 IND approvals.

Toward the mission of "Innovation through Collaboration", GenScript ProBio is committed to helping customers shorten the timeline for the development of biological drugs from discovery to commercialization, significantly lowering R&D costs and building a healthier future.

www.genscriptprobio.com
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    News WorldWide

    MOPA
    ​Media, 
    All-In-One Agency, Blockchain Development

    Online Service

    ​Media
    ​Branding
    ​Celebrity Content
    ​Cultural Exchange
    Digital Marketing
    Public Relations
    Makeup
    Blockchain Project

    Our location:
    ​
    Auckland, ​New Zealand​
    Brisbane, Australia
    Shanghai, China
    Singapore


    Email:  info@mopa1.com
    Picture
     

    Archives

    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    April 2021
    March 2021
    February 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    August 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    October 2016
    November 2014
    August 2014
    July 2014
    April 2014
    March 2014
    February 2014
    October 2013
    September 2013
    June 2013

    Categories

    All
    Asia Pacific
    Australia
    Brazil
    Chile
    China
    Cuba
    Japan
    Latin America
    Mexico
    Singapore
    United States
    Venezuela
    Vietnam

    RSS Feed

Powered by Create your own unique website with customizable templates.